Write For Us

AstraZeneca COVID-19 sales jump despite challenges

Sponsored Post Vitamin D2 Canada Persia
61 Views
Published
Second-quarter sales of AstraZeneca's COVID-19 vaccine more than tripled to $894 million from the first quarter, but the drugmaker again delayed its U.S. application for approval as it gathers more data for submissions.

#News #Reuters #AstraZeneca #results #COVID #vaccine

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, business, finance
Sign in or sign up to post comments.
Be the first to comment